BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lai Q, Melandro F, Larghi Laureiro Z, Giovanardi F, Ginanni Corradini S, Ferri F, Hassan R, Rossi M, Mennini G. Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(15): 1658-1665 [PMID: 29686473 DOI: 10.3748/wjg.v24.i15.1658]
URL: https://www.wjgnet.com/1007-9327/full/v24/i15/1658.htm
Number Citing Articles
1
José Sánchez Segura, Francisco Javier León Díaz, María Pérez Reyes, Daniel Cabañó Muñoz, Belinda Sánchez Pérez, Jose Antonio Pérez Daga, Custodia Montiel Casado, Julio Santoyo Santoyo. Predictive Models of Hepatocellular Carcinoma Recurrence After Liver TransplantationTransplantation Proceedings 2020; 52(2): 546 doi: 10.1016/j.transproceed.2019.11.048
2
Media N. Ismael, Justin Forde, Eduardo Milla, Walid Khan, Roniel Cabrera. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver TransplantationBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7284040
3
Agata Michalak, Halina Cichoż-Lach, Małgorzata Guz, Joanna Kozicka, Marek Cybulski, Witold Jeleniewicz, Andrzej Stepulak. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scalesWorld Journal of Gastroenterology 2020; 26(47): 7538-7549 doi: 10.3748/wjg.v26.i47.7538
4
Riccardo Pravisani, Federico Mocchegiani, Miriam Isola, Dario Lorenzin, Gian Luigi Adani, Vittorio Cherchi, Maria De Martino, Andrea Risaliti, Quirino Lai, Marco Vivarelli, Umberto Baccarani. Postoperative Trends and Prognostic Values of Inflammatory and Nutritional Biomarkers after Liver Transplantation for Hepatocellular CarcinomaCancers 2021; 13(3): 513 doi: 10.3390/cancers13030513
5
Weijuan Cao, Xiaomin Yao, Danwei Cen, Yajun Zhi, Ningwei Zhu, Liyong Xu. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1167-x
6
Lixing Liu, Yang Gong, Qinglin Zhang, Panpan Cai, Li Feng. Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-AnalysisFrontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01557
7
文燕 章. Molecular Markers and Recurrence of Hepatocellular Carcinoma after Liver TransplantationAdvances in Clinical Medicine 2019; 9(03): 310 doi: 10.12677/ACM.2019.93047
8
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
9
Marcin Nylec, Kamil Derbisz, Patrycja Chrząszcz, Weronika Wrońska, Robert Król, Wojciech Wystrychowski. Preoperative Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of 1-Year Graft Loss and Mortality After Orthotopic Liver TransplantationTransplantation Proceedings 2020; 52(8): 2472 doi: 10.1016/j.transproceed.2020.03.036
10
Hugo Pinto Marques, Sílvia Gomes da Silva, Eleonora De Martin, Vatche G. Agopian, Paulo N. Martins. Emerging biomarkers in HCC patients: Current statusInternational Journal of Surgery 2020; 82: 70 doi: 10.1016/j.ijsu.2020.04.043
11
Xiaohui Zhi, Kan Jiang, Yue Shen, Xinyu Su, Ke Wang, Yuanyuan Ma, Liqing Zhou. Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non‐surgical esophageal squamous cell carcinoma patients treated with radiotherapyJournal of Clinical Laboratory Analysis 2020; 34(10) doi: 10.1002/jcla.23468
12
Nourhan Badwei, Waheed A. Monsef, Iman Montasser, Mohamed Bahaa, Mahmoud El Meteini, Shimaa Y. Kamel. Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantationEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00105-8
13
Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantationWorld Journal of Hepatology 2019; 11(1): 50-64 doi: 10.4254/wjh.v11.i1.50
14
Cem Onal, Ali Murat Sedef, Fatih Kose, Ezgi Oymak, Ozan Cem Guler, Ahmet Taner Sumbul, Sercan Aksoy, Berna Akkus Yildirim, Ali Ayberk Besen, Sadık Muallaoglu, Huseyin Mertsoylu, Gokhan Ozyigit. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateFuture Oncology 2019; 15(13): 1469 doi: 10.2217/fon-2018-0635
15
Quirino Lai, Alessandro Vitale, Tommaso Manzia, Francesco Foschi, Giovanni Levi Sandri, Martina Gambato, Fabio Melandro, Francesco Russo, Luca Miele, Luca Viganò, Patrizia Burra, Edoardo Giannini. Platelets and Hepatocellular Cancer: Bridging the Bench to the ClinicsCancers 2019; 11(10): 1568 doi: 10.3390/cancers11101568
16
Mohamed A. Abdallah, Nicha Wongjarupong, Mohamed A. Hassan, Wesam Taha, Abubaker Abdalla, Sally Bampoh, Kristeen Onyirioha, Morgan Nelson, Lyn A. Glubranson, Gregory A. Wiseman, Chad J. Fleming, James C. Andrews, Amit Mahipal, Lewis R. Roberts. The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective studyExpert Review of Gastroenterology & Hepatology 2020; 14(7): 619 doi: 10.1080/17474124.2020.1777856
17
UEG Week 2019 Poster PresentationsUnited European Gastroenterology Journal 2019; 7(S8): 189 doi: 10.1177/2050640619854671
18
梓聿 王. Correlation between SII/ALB and the Prognosis of EGFR Gene Mutation in Advanced Non-Small Cell Lung CancerAdvances in Clinical Medicine 2020; 10(06): 857 doi: 10.12677/ACM.2020.106131
19
Riccardo Pravisani, Federico Mocchegiani, Miriam Isola, Dario Lorenzin, Gian Luigi Adani, Vittorio Cherchi, Elda Righi, Giovanni Terrosu, Marco Vivarelli, Andrea Risaliti, Umberto Baccarani. Controlling Nutritional Status score does not predict patients' overall survival or hepatocellular carcinoma recurrence after deceased donor liver transplantationClinical Transplantation 2020; 34(3) doi: 10.1111/ctr.13786